US 11266726
Compositions and methods for the treatment of HER2-expressing solid tumors
granted A61KA61K2039/5256A61K40/19
Quick answer
US patent 11266726 (Compositions and methods for the treatment of HER2-expressing solid tumors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/5256, A61K40/19, A61K40/24, A61K40/30